mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |